ADGRL3 and cancer: Additionally, 17 potential therapeutic targets (AKT1, CCND1, CASP3, CTNNB1, EGF, EGFR, ESR1, HIF1A, HSP90AA1, IL6, JUN, MYC, MAPK3, PTEN, STAT3, TP53, VEGFA) were directly related to the KEGG pathway “cancer” and linked to 30 compounds (SQ7, ZJ11, ZJ3, ZJ4, CBM9, CF2, CF3, QYS8, QYS9, ZJ8, CL3, CL5, ZJ6, CL2, ZJ10, ZJ12, ZJ2, DSL4, DSL5, DSL6, ZZS1, CF1, CF10, GC12, GC16, GC37, QYS3, SQ13, XYS24, CBM16; Table S2).